Twist BioScience Lawsuit TWST | Deadline February 10, 2023

Twist BioScience Class Action Lawsuit (TWST Lawsuit)

A lawsuit has been filed against the Twist BioScience, (TWST:NASDAQ) on December 12, 2022 at the court of the Northern District of California.

Investors who purchased or otherwise acquired TWST common stock during the period from December 13, 2019, – November 14, 2022 can register their information before the deadline of  February 10, 2023.

Is Twist BioScience Involved  in a Securities Class Action Lawsuit?

Yes, a lawsuit has been filed against Twist BioScience on December 10, 2022, on behalf of shareholders during the period from December 13, 2019, – November 14, 2022.

What Is The Twist BioScience Lawsuit About?

The Twist BioScience Class Action Lawsuit (NASDAQ:TWST) (Twist BioScience Class Action Lawsuit) was filed on behalf of the investors who purchased Twist BioScience Class Action Lawsuit (TWST) securities between December 13, 2019, – November 14, 2022, inclusive. For more on the TWST Lawsuit contact us today.

According to the Twist BioScience lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:

1) as alleged in the November 15, 2022 report by Scorpion Capital, defendants overstated the commercial viability of Twist’s synthetic DNA manufacturing technology; and

2) at the same time, defendants were engaging in accounting fraud and using unsustainable pricing to inflate the Company’s true financial condition and prospects.

If you suffered a loss in Twist BioScience, Inc. you have until February 10, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

How much did TWST stock drop?

Shareholders who held Twist BioScience’s ordinary share stock fell $7.57 per share, or nearly 20%, from a close of $38.00 per share on November 14, 2022, to close at $30.43 per share on November 15, 2022.

What does TWST Do?

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.

The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.

The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools.

It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets.

The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Which Class Action Attorney Firm Can Help With The TWST Lawsuit?

Levi & Korsinsky LLP is a Securities Class Action Law Firm.  For over 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

If I register do I have to be a Lead Plaintiff?

No, you do not have to be a lead plaintiff if you register.  You will receive regular updates of the class action, including, should a settlement be reached, the information of a settlement and how to claim your losses.

Does It Cost Me To Join The TWST Class Action?

No, there are no out of pocket costs for you to join Twist BioScience Lawsuit.

What Is the Lead Plaintiff Process?

According to the Private Securities Reform Act of 1995, any investor who bought or acquired TWST securities in the Class Period may apply for appointment as a lead plaintiff. The lead plaintiff is usually the movant who has the most financial interest in the relief sought. However, he or she must also be typical or adequate to the putative classes. The TWST class-action lawsuit is directed by the lead plaintiff. To litigate the Twist BioScience Class Action Lawsuit, the lead plaintiff may choose any law firm it wishes. The ability of an investor to share in any future recovery is not tied to being the lead plaintiff in the Twist BioScience.

Have other shares in other companies? Search Class Action Cases.